[go: up one dir, main page]

PT946190E - Metodos e composicoes para estimular o crescimento de neurites - Google Patents

Metodos e composicoes para estimular o crescimento de neurites

Info

Publication number
PT946190E
PT946190E PT97947533T PT97947533T PT946190E PT 946190 E PT946190 E PT 946190E PT 97947533 T PT97947533 T PT 97947533T PT 97947533 T PT97947533 T PT 97947533T PT 946190 E PT946190 E PT 946190E
Authority
PT
Portugal
Prior art keywords
compositions
methods
neurite growth
stimulating neurite
stimulating
Prior art date
Application number
PT97947533T
Other languages
English (en)
Inventor
Robert E Zelle
Michael Su
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25009484&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT946190(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of PT946190E publication Critical patent/PT946190E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Psychology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT97947533T 1996-11-13 1997-11-13 Metodos e composicoes para estimular o crescimento de neurites PT946190E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/748,447 US5840736A (en) 1996-11-13 1996-11-13 Methods and compositions for stimulating neurite growth

Publications (1)

Publication Number Publication Date
PT946190E true PT946190E (pt) 2004-02-27

Family

ID=25009484

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97947533T PT946190E (pt) 1996-11-13 1997-11-13 Metodos e composicoes para estimular o crescimento de neurites

Country Status (33)

Country Link
US (3) US5840736A (pt)
EP (1) EP0946190B1 (pt)
JP (1) JP2001504470A (pt)
KR (1) KR100544451B1 (pt)
CN (1) CN1168442C (pt)
AP (1) AP9901518A0 (pt)
AR (1) AR011278A1 (pt)
AT (1) ATE250424T1 (pt)
AU (1) AU724833B2 (pt)
BG (1) BG64670B1 (pt)
BR (1) BR9712765A (pt)
CA (1) CA2270634A1 (pt)
CO (1) CO4930260A1 (pt)
CZ (1) CZ296058B6 (pt)
DE (1) DE69725169T2 (pt)
DK (1) DK0946190T3 (pt)
EA (1) EA004247B1 (pt)
ES (1) ES2206753T3 (pt)
HK (1) HK1022851A1 (pt)
HU (1) HU226728B1 (pt)
IL (1) IL129555A (pt)
IN (1) IN183740B (pt)
IS (1) IS2057B (pt)
NO (1) NO328030B1 (pt)
NZ (1) NZ335394A (pt)
PL (1) PL190903B1 (pt)
PT (1) PT946190E (pt)
SK (1) SK284535B6 (pt)
TR (1) TR199901034T2 (pt)
TW (1) TW513302B (pt)
UA (1) UA63926C2 (pt)
WO (1) WO1998020891A1 (pt)
ZA (1) ZA9710256B (pt)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859031A (en) 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5780484A (en) * 1996-11-13 1998-07-14 Vertex Pharmaceuticals Incorporated Methods for stimulating neurite growth with piperidine compounds
US6242468B1 (en) 1997-02-27 2001-06-05 Jia-He Li Carbamate and urea compositions and neurotrophic uses
US6514686B2 (en) 1997-04-28 2003-02-04 The University Of British Columbia Method and composition for modulating amyloidosis
US5945441A (en) 1997-06-04 1999-08-31 Gpi Nil Holdings, Inc. Pyrrolidine carboxylate hair revitalizing agents
US6852496B1 (en) * 1997-08-12 2005-02-08 Oregon Health And Science University Methods of screening for agents that promote nerve cell growth
US5968921A (en) 1997-10-24 1999-10-19 Orgegon Health Sciences University Compositions and methods for promoting nerve regeneration
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
JP2002516904A (ja) 1998-06-03 2002-06-11 ジーピーアイ ニル ホールディングス インコーポレイテッド Ｎ−複素環式カルボン酸またはカルボン酸等配電子体のｎ−結合スルホンアミド
YU2901A (sh) 1998-07-17 2004-05-12 Agouron Pharmaceuticals Inc. Jedinjenja, kompozicije i postupci za stimulisanje neuronskog rasta i elongacija
GB9815880D0 (en) 1998-07-21 1998-09-16 Pfizer Ltd Heterocycles
US6395758B1 (en) 1998-08-14 2002-05-28 Gpi Nil Holdings, Inc. Small molecule carbamates or ureas for vision and memory disorders
US6218423B1 (en) 1998-08-14 2001-04-17 Gpi Nil Holdings, Inc. Pyrrolidine derivatives for vision and memory disorders
US6462072B1 (en) 1998-09-21 2002-10-08 Gpi Nil Holdings, Inc. Cyclic ester or amide derivatives
US6300341B1 (en) 1998-09-30 2001-10-09 The Procter & Gamble Co. 2-substituted heterocyclic sulfonamides
US6307049B1 (en) 1998-09-30 2001-10-23 The Procter & Gamble Co. Heterocyclic 2-substituted ketoamides
US6228872B1 (en) 1998-11-12 2001-05-08 Bristol-Myers Squibb Company Neurotrophic diamide and carbamate agents
DE69923998T2 (de) * 1998-12-09 2006-04-27 Chiron Corp., Emeryville Verwendung eines neurologischen wirkstoffes zur herstellung eines medikamentes zur behandlung von erkrankungen des zentralen nervensystems
AU2407400A (en) * 1999-01-08 2000-07-24 Vertex Pharmaceuticals Incorporated Process for the formation of intermediates useful for the preparation of pharmaceuticals
EP1196389A1 (en) 1999-07-06 2002-04-17 Vertex Pharmaceuticals Incorporated N-heterocyclic derivatives with neuronal activity
US6734211B1 (en) 1999-07-09 2004-05-11 Oregon Health & Sciences University Compositions and methods for promoting nerve regeneration
AU6497200A (en) * 1999-07-30 2001-02-19 Vertex Pharmaceuticals Incorporated Acyclic and cyclic amine derivatives
US6417189B1 (en) 1999-11-12 2002-07-09 Gpi Nil Holdings, Inc. AZA compounds, pharmaceutical compositions and methods of use
DK1227859T3 (da) * 1999-11-12 2006-12-11 Alcon Inc Neurophilinligander til behandling af okulære tilstande
US7253169B2 (en) 1999-11-12 2007-08-07 Gliamed, Inc. Aza compounds, pharmaceutical compositions and methods of use
US6818643B1 (en) 1999-12-08 2004-11-16 Bristol-Myers Squibb Company Neurotrophic bicyclic diamides
US7060676B2 (en) * 1999-12-20 2006-06-13 Trustees Of Tufts College T. cruzi-derived neurotrophic agents and methods of use therefor
JP2003518122A (ja) 1999-12-21 2003-06-03 ジーピーアイ エヌアイエル ホールディングズ インコーポレーテッド ヒダントイン誘導体化合物、医薬合成品およびこれらの使用方法
US6555573B2 (en) * 2000-12-21 2003-04-29 The Quigley Corporation Method and composition for the topical treatment of diabetic neuropathy
ATE554784T1 (de) * 2001-05-25 2012-05-15 Cornell Res Foundation Inc Hochaffiner ligand für p75 neurotrophin-rezeptor
EP1404325A2 (en) * 2001-05-29 2004-04-07 Guilford Pharmaceuticals Inc. Method for treating nerve injury caused by surgery
FR2825273B1 (fr) * 2001-05-29 2006-11-24 Oreal Composition pour le traitement des signes cutanes du vieillissement
US20030118536A1 (en) * 2001-11-06 2003-06-26 Rosenbloom Richard A. Topical compositions and methods for treatment of adverse effects of ionizing radiation
US7435725B2 (en) * 2001-11-06 2008-10-14 The Quigly Corporation Oral compositions and methods for prevention, reduction and treatment of radiation injury
US20030105027A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
AU2002363800A1 (en) * 2001-11-13 2003-05-26 Loi Tran Therapeutic agent composition and method of use
US7232798B2 (en) 2001-11-13 2007-06-19 Tran Loi H Neuroprotection and neuroegenisis by administering cyclic prolyl glycine
US20100247483A1 (en) * 2001-11-13 2010-09-30 Tran Loi H Therapeutic agent composition and method of use
US7083813B2 (en) * 2002-11-06 2006-08-01 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
US8841326B2 (en) 2004-02-12 2014-09-23 Stc.Unm Therapeutic curcumin derivatives
JP2009525319A (ja) * 2006-02-02 2009-07-09 ライナット ニューロサイエンス コーポレイション ｔｒｋＢアンタゴニストを投与することにより肥満を治療する方法
DOP2007000021A (es) * 2006-02-02 2007-08-31 Rinat Neuroscience Corp Procedimientos para tratar pérdida de peso no deseada o trastornos alimentarios administrando un agonista de trkb
EP2114436A1 (en) * 2006-12-20 2009-11-11 Rinat Neuroscience Corp. Trkb agonists for treating autoimmune disorders
US20090018151A1 (en) * 2007-02-23 2009-01-15 Ezekiel Fink Topical Treatment of Peripheral diabetic complications
WO2019222339A1 (en) 2018-05-15 2019-11-21 Tran Lloyd Hung Loi Therapeutic agent composition and method of use, for treatment of mild cognitive impairment, depression, and psychological disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798355A (en) 1995-06-07 1998-08-25 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity
IL115685A (en) * 1994-11-16 2000-08-31 Vertex Pharma Amino acid derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
US5543423A (en) * 1994-11-16 1996-08-06 Vertex Pharmaceuticals, Incorporated Amino acid derivatives with improved multi-drug resistance activity
US5614547A (en) * 1995-06-07 1997-03-25 Guilford Pharmaceuticals Inc. Small molecule inhibitors of rotamase enzyme
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5696135A (en) * 1995-06-07 1997-12-09 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US6037370A (en) 1995-06-08 2000-03-14 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5801197A (en) * 1995-10-31 1998-09-01 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
US5811434A (en) * 1996-11-13 1998-09-22 Vertex Pharmacueticals Incorporated Methods and compositions for stimulating neurite growth
CN104718162B (zh) * 2012-09-28 2017-11-21 Dic株式会社 α‑氧化铝微粒以及其制造方法

Also Published As

Publication number Publication date
IS2057B (is) 2005-10-14
US6284778B1 (en) 2001-09-04
SK62899A3 (en) 2000-04-10
NO328030B1 (no) 2009-11-16
WO1998020891A1 (en) 1998-05-22
US6172086B1 (en) 2001-01-09
US5840736A (en) 1998-11-24
AU724833B2 (en) 2000-09-28
ES2206753T3 (es) 2004-05-16
AP9901518A0 (en) 1999-06-30
ZA9710256B (en) 1998-05-28
IL129555A0 (en) 2000-02-29
HUP0001219A2 (hu) 2000-11-28
NO992138D0 (no) 1999-05-03
SK284535B6 (sk) 2005-06-02
CN1168442C (zh) 2004-09-29
UA63926C2 (uk) 2004-02-16
DE69725169T2 (de) 2004-07-15
BG64670B1 (bg) 2005-11-30
KR100544451B1 (ko) 2006-01-24
HK1022851A1 (en) 2000-08-25
EA004247B1 (ru) 2004-02-26
IS5032A (is) 1999-04-21
KR20000068962A (ko) 2000-11-25
CZ296058B6 (cs) 2006-01-11
EP0946190A1 (en) 1999-10-06
DK0946190T3 (da) 2003-12-08
TR199901034T2 (xx) 1999-07-21
PL333270A1 (en) 1999-11-22
CN1239433A (zh) 1999-12-22
CZ168399A3 (cs) 1999-08-11
HU226728B1 (en) 2009-08-28
PL190903B1 (pl) 2006-02-28
HUP0001219A3 (en) 2001-12-28
BG103429A (en) 2000-04-28
ATE250424T1 (de) 2003-10-15
BR9712765A (pt) 1999-10-26
JP2001504470A (ja) 2001-04-03
DE69725169D1 (de) 2003-10-30
IL129555A (en) 2005-08-31
CO4930260A1 (es) 2000-06-27
AU5258998A (en) 1998-06-03
NZ335394A (en) 2000-06-23
EA199900464A1 (ru) 2000-02-28
IN183740B (pt) 2000-04-01
TW513302B (en) 2002-12-11
AR011278A1 (es) 2000-08-16
EP0946190B1 (en) 2003-09-24
CA2270634A1 (en) 1998-05-22
NO992138L (no) 1999-07-13

Similar Documents

Publication Publication Date Title
PT946190E (pt) Metodos e composicoes para estimular o crescimento de neurites
IL129556A0 (en) Pharmaceutical compositions and methods for stimulating neurite growth
ZA9710248B (en) Methods and compositions for stimulating neurite growth.
BR9711663A (pt) M-tod e composi-Æo para tratamento de substrato umedecidos
DE69812603D1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
BR9609132A (pt) Composicão e método de tratamento de semente
GR3036364T3 (en) Compositions and methods for treating or preventing inflammatory diseases
BR9604872A (pt) Composição para tratamento de cabelo
DE69707905D1 (de) Zusammensetzung zur remineralisierung
DE69722320D1 (de) Skelettimplantat
EP0946158A4 (en) COMPILATION AND METHOD FOR TANING THE SKIN
DE69728356D1 (de) Vernetzbare Zusammensetzung
DE69603089D1 (de) Zusammensetzung zur behandlung von mauerwerk
DK0926952T3 (da) Antimikrobiel sammensætning og fremgangsmåde til fremstilling deraf
DE69602847D1 (de) Tuberkilizide synergistische desinfizierende zusammensetzung und verfahren zur desinfektion
ID21987A (id) Komposisi dan metode untuk biji yang menguntungkan
NO985385L (no) Bitumensammensetninger og fremgangsmÕte for fremstilling derav
FI965008A0 (fi) Koostumukset ja menetelmät kasvainten hoitamiseksi
DE69721756D1 (de) Paroxetine zur behandlung von depression
BR9708246A (pt) Metodo para tratamento de dor
DE69729604D1 (de) Zusammensetzung zur Geruchsverstärkung
DE69708418D1 (de) Naphthylverbindungen und Zusammensetzungen
FR2746261B1 (fr) Composition insecticide et procede de preparation
BR9710544A (pt) M-todo de tratamento composto e composi-Æo farmac-utica
DE69930603D1 (de) Zusammensetzung zur Wiederherstellung und Stimulierung der Hautbarrierefunktion